Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice
Open Access
- 12 February 2020
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 476, 57-66
- https://doi.org/10.1016/j.canlet.2020.02.005
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Georgia Cancer Coalition
- National Institutes of Health (CA160216, CA172048, CA062130)
- American Cancer Society (IRG-14-193-01)
This publication has 31 references indexed in Scilit:
- The Human Polyomavirus Middle and Alternative T-Antigens; Thoughts on Roles and Relevance to CancerFrontiers in Microbiology, 2018
- Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesisOncotarget, 2017
- GT198 Expression Defines Mutant Tumor Stroma in Human Breast CancerThe American Journal of Pathology, 2016
- Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian CancersGenes & Cancer, 2013
- XX Ovarian Dysgenesis Is Caused by a PSMC3IP/HOP2 Mutation that Abolishes Coactivation of Estrogen-Driven TranscriptionAmerican Journal of Human Genetics, 2011
- Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancerVirology, 2008
- Exposure on Cell Surface and Extensive Arginine Methylation of Ewing Sarcoma (EWS) ProteinPublished by Elsevier ,2001
- Natural Biology of Polyomavirus Middle T AntigenMicrobiology and Molecular Biology Reviews, 2001
- Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11bOncogene, 1997
- Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.Proceedings of the National Academy of Sciences, 1992